NCT02476734View on ClinicalTrials.gov

FDG-PET/CT Imaging as Early Predictor of DP

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2018

Conditions
Lymphoma
Interventions
OTHER

There is no intervention

Subjects undergo FDG-PET CT scans in order to determine lesional FDG intake and changes in lesional FDG uptake.

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02476734 - FDG-PET/CT Imaging as Early Predictor of DP | Biotech Hunter | Biotech Hunter